HSLV Q1 2026 Earnings Massive EPS Surprise Despite Stock Decline ProQR Therapeutics Q1 2026 Earnings Narrower Net Loss No Revenue as Pipeline Progress Drives Stock Gains CCEP Q4 2018 Earnings Slight EPS Miss Highlights Cost Pressures TSHA Q1 2026 Earnings WiderthanExpected Loss as Company Continues Development Pipeline CTO Q1 2026 Earnings Massive EPS Surprise of 374 as FFO Exceeds Expectations LUMN Q1 2026 Earnings Significant EPS Miss as Company Faces Ongoing Challenges